Answers are grounded in this paper and cite their sources.
Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem disorder marked by profound fatigue, cognitive impairment, and post-exertional symptom exacerbation. Because therapeutic strategies for ME/CFS are limited, self-management through dietary supplements may provide affected individuals with a sense of control in managing this chronic illness. Methods A structured questionnaire was distributed to women diagnosed with ME/CFS. Data on illness duration, symptoms, functional capacity, supplement use, and dietary restrictions were collected. Secondary analyses focused on participants' access to supplements, sources of information, and communication with physicians. Supplements were categorized based on established classification systems. Results There were 268 valid responses (Age, 43 ± 14y; ME/CFS duration, 8.8 ± 9.5y). Participants were highly impaired, with 28% classified as functionally housebound. Supplement use was highly prevalent (91%), and supplement users reported a mean of 8±7 different supplements. Perceived symptom improvement ( P < 0.001) and higher participant education ( P = 0.02) were associated with greater supplement use. Supplement-related concerns, including cost ($106 USD/month) and access, represented significant sources of participant stress. Only half of participants reported disclosing all supplements to their physician. Dietary restrictions were reported by 30% of respondents, with gluten-free, lactose-restricted, and high-protein diets being the most common. Conclusions Supplement use is highly prevalent in ME/CFS, but current scientific evidence supporting their widespread therapeutic use remains limited. As a result, many participants resort to a trial-and-error approach and may engage in excessive supplementation. Continued research assessing the effectiveness of dietary interventions and supplements will enable healthcare professionals to offer evidence-based guidance to improve symptom management and reduce patient burden.
No takes yet. Share an insight, caveat, or question.
Shaw et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: